Company is focused on endocannabinoid system treatments
Category: News
Data supports Poolbeg’s strategic expansion of POLB 001
License agreement concerns development of cell therapies for corneal blindness
Aston University to create the Aston Institute for Membrane Excellence
EUR 20m to identify new targets and develop first in class drugs
Companies collaborate to launch walk-in pain clinic
CellVoyant’s platform combines AI with live cell imaging
Researchers compared 20 years of antibiotic use on E. coli in the UK and Norway
If successful, the new test could see routine screening introduced in the NHS
The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser